Trial results show immunotherapy & targeted drugs could stop melanomas returning

Some of the treatments currently used for certain advanced melanomas could be effective in those with an earlier stage of disease after surgery, according to results from two clinical trials. The studies (Checkmate 238 and COMBI-AD) examined an immunotherapy drug and a combination of targeted drugs respectively, the results showed that both types of treatment

Continue Reading

Cancer Research UK reports immunotherapy drug that can extend life of cancer patients

A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects, according to preliminary results from a late stage clinical trial. “This is another great example of how research into the immune system can deliver powerful new treatments” – Professor Peter Johnson, Cancer Research UK. Patients with

Continue Reading